- 英文名称
- Ro 32-0432
- 分子式
- C28H28N4O2
- 分子量
- 452.55
- 中文别名
- Ro 32-0432 hydrochloride; ro 32-0432; Ro 32-0432 hydrochloride; Ro-32-0432; CHEMBL26501; RO-320432; (S)-3-(8-((Dimethylamino)methyl)-6,7,8,9-tetrahydropyrido(1,2-a)indol-10-yl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrol-2,5-dione; ro32-0432; (S)-Ro 32-0432 (free base); 1H-Pyrrole-2,5-dione, 3-[(8S)-8-[(dimethylamino)methyl]-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl]-4-(1-methyl-1H-indol-3-yl)-; 3-[(8S)-8-[(Dimethylamino)methyl]-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl]-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione; 3-[(8S)-8-[(dimethylamino)methyl]-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione; (S)-3-(8-((Dimethylamino)methyl)-6,7,8,9-tetrahydropyrido(1,2-a)indol-10-yl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione; 1H-Pyrrole-2,5-dione, 3-(8-((dimethylamino)methyl)-6,7,8,9-tetrahydropyrido(1,2-a)indol-10-yl)-4-(1-methyl-1H-indol-3-yl)-, (S)-; (S)-3-(8-((dimethylamino)methyl)-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione; 1H-Pyrrole-2,5-dione, 3-[8-[(dimethylamino)methyl]-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl]-4-(1-methyl-1H-indol-3-yl)-, (S)-; MFCD01319127; 4Q5QZ7WCZ2; GTPL6034; orb1704153; SCHEMBL1566370; SCHEMBL29664388; FXGHOAZJQNLNFD-KRWDZBQOSA-N; DTXSID701103763; (S)-Ro 32-0432 free base; BDBM50282633; NSC767288; AKOS040745331; NSC-767288; SDCCGRCH-0000147.P001; SDCCGSBI-0640311.P001; 1H-Pyrrol-2,5-dione, 3-(8-((dimethylamino)methyl)-6,7,8,9-tetrahydropyrido(1,2-a)indol-10-yl)-4-(1-methyl-1H-indol-3-yl)-, (S)-; DA-59695; HY-108601; CS-0029283; T23244; Q27088582; 3-((S)-8-Dimethylaminomethyl-6,7,8,9-tetrahydro-pyrido[1,2-a]indol-10-yl)-4-(1-methyl-1H-indol-3-yl)-pyrrole-2,5-dione; 3-[(2S)-2-[(dimethylamino)methyl]-1H,2H,3H,4H-pyrido[1,2-a]indol-10-yl]-4-(1-methyl-1H-indol-3-yl)-2,5-dihydro-1H-pyrrole-2,5-dione
- 用途
- 生命科学领域，作为有效、选择性和口服活性的PKC抑制剂，用于慢性炎症和自身免疫性疾病研究；同时是选择性GRK5抑制剂，可防止T细胞活化。
